# Regimen Switch After Intensive Insulin Therapy

> **NCT04833413** · — · UNKNOWN · sponsor: **Shanghai Zhongshan Hospital** · enrollment: 1000 (estimated)

## Conditions studied

- Insulin

## Interventions

- **DRUG:** Continuous intensive insulin therapy

## Key facts

- **NCT ID:** NCT04833413
- **Lead sponsor:** Shanghai Zhongshan Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-04-15
- **Primary completion:** 2023-12-31
- **Final completion:** 2024-05-31
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2023-06-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04833413

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04833413, "Regimen Switch After Intensive Insulin Therapy". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04833413. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*